TareBio is a HealthTech platform focused on accelerating vaccine development for any disease. By leveraging the body’s existing immune response, the platform identifies antigens that naturally activate immune cells fighting a specific condition. This approach eliminates the need for lengthy trial-and-error antigen selection, enabling rapid design of vaccines tailored to individual patients or entire populations.
The system operates by analyzing immune cells directly from patients and reconstructing the precise antigens that trigger their activity. This reverse-engineering method has already been validated in full through experimental testing, resulting in a vaccine that successfully treated cancer in mouse models. The technology represents a shift from predictive modeling to real-time immune feedback, offering a faster pathway to effective immunotherapies.